Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(17)
•••
mstrmnds
X
View Profile
View Bullboard History
Post by
mstrmnds
on Apr 01, 2024 11:39am
Acquisition - Europe?
It looks like someone from Europe is at the negotiating table
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Apr 01, 2024 11:33am
RE:Acquisition
i disagree, the only interest might be in hireing the top players from ATE on a temporary basis after ate goes bankrupt. to finish P2 if unsuccessful they will get the boot. if successful they will
...more
(17)
•••
mstrmnds
X
View Profile
View Bullboard History
Post by
mstrmnds
on Apr 01, 2024 11:14am
Acquisition
This company is on the radar for several big players
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Apr 01, 2024 11:06am
RE:FDA Hold
That is right they have no money to run P2, that means they could not find anyone to finance them, all avenues must be exhausted by now. and nuance wants there money. it is over, some investors are
...more
(17)
•••
mstrmnds
X
View Profile
View Bullboard History
Post by
mstrmnds
on Apr 01, 2024 10:57am
FDA Hold
It's because of harm to patients due to insufficient funding (safety monitoring) It has nothing to do with Otena
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Apr 01, 2024 10:48am
The one two punch📉
that has antibe on life supprt Antibe Therapeutics Inc. (“Antibe” or the “Company” TSX: ATE, OTCQX: ATBPF) today announced that it received verbal notice on the afternoon of March 28, 2024 from the
...more
(15)
•••
SimonSaysLues
X
View Profile
View Bullboard History
Post by
SimonSaysLues
on Apr 01, 2024 10:35am
Mugsy you are awfully quiet today
C cat got your tongue?
(15)
•••
SimonSaysLues
X
View Profile
View Bullboard History
Comment by
SimonSaysLues
on Apr 01, 2024 10:24am
RE:RE:RE:Acquisition
I believe the ate building is Dan's ....
(55)
•••
Harper75
X
View Profile
View Bullboard History
Comment by
Harper75
on Apr 01, 2024 10:13am
RE:RE:RE:Acquisition
Depends on the rationale for the pause. I was expecting litigation but the pause speaks to the science. IDK...
(17)
•••
mstrmnds
X
View Profile
View Bullboard History
Comment by
mstrmnds
on Apr 01, 2024 10:11am
RE:RE:Acquisition
The assets are worth exponentially more than the current market cap It's going to be acquired
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Apr 01, 2024 10:05am
RE:Acquisition
are you that foolish, have you not lost enough yet, my guess is dan did not tell you about this in your conversation. or was there a conversation at all i still call B.S.
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Apr 01, 2024 9:57am
It is over
the dead carcass of what was antibe is now being picked away at by day traders and the vultures, nuance wants there money and will be forced to go through the process, while antibe slowly burns the
...more
(17)
•••
mstrmnds
X
View Profile
View Bullboard History
Post by
mstrmnds
on Apr 01, 2024 9:53am
Acquisition
Added another 100K This company will likely be acquired
(15)
•••
SimonSaysLues
X
View Profile
View Bullboard History
Post by
SimonSaysLues
on Apr 01, 2024 9:53am
Clown car with Dan/Mugs at the helm!
Mugs still full of optimism. !! Time to buy lol.
(3)
•••
CalmBeforeStorm
X
View Profile
View Bullboard History
Comment by
CalmBeforeStorm
on Apr 01, 2024 9:52am
RE:Painful lesson
I'm going to be on the French Riviera in a few days. Perhaps I should make a point a making a few minutes detour to the sailing community of Antibes to see if there are any boats flying Canadian
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >